Achieve Life Sciences Inc (NASDAQ: ACHV) on Friday, soared 0.65% from the previous trading day, before settling in for the closing price of $3.07. Within the past 52 weeks, ACHV’s price has moved between $3.07 and $5.59.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 18.58%. With a float of $27.60 million, this company’s outstanding shares have now reached $34.39 million.
In an organization with 22 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Achieve Life Sciences Inc (ACHV) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Achieve Life Sciences Inc is 19.75%, while institutional ownership is 48.86%. The most recent insider transaction that took place on Mar 04 ’24, was worth 45,850. In this transaction Executive Chairman of this company bought 10,000 shares at a rate of $4.58, taking the stock ownership to the 38,501 shares. Before that another transaction happened on Mar 04 ’24, when Company’s CEO bought 10,000 for $4.58, making the entire transaction worth $45,850. This insider now owns 76,724 shares in total.
Achieve Life Sciences Inc (ACHV) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.35 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 18.58% per share during the next fiscal year.
Achieve Life Sciences Inc (NASDAQ: ACHV) Trading Performance Indicators
Achieve Life Sciences Inc (ACHV) is currently performing well based on its current performance indicators. A quick ratio of 6.78 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.13, a number that is poised to hit -0.34 in the next quarter and is forecasted to reach -1.14 in one year’s time.
Technical Analysis of Achieve Life Sciences Inc (ACHV)
Let’s dig in a bit further. During the last 5-days, its volume was 0.22 million. That was inferior than the volume of 0.35 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 11.34%. Additionally, its Average True Range was 0.21.
During the past 100 days, Achieve Life Sciences Inc’s (ACHV) raw stochastic average was set at 3.06%, which indicates a significant decrease from 8.33% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 59.32% in the past 14 days, which was higher than the 43.83% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.09, while its 200-day Moving Average is $4.57. However, in the short run, Achieve Life Sciences Inc’s stock first resistance to watch stands at $3.15. Second resistance stands at $3.20. The third major resistance level sits at $3.27. If the price goes on to break the first support level at $3.03, it is likely to go to the next support level at $2.96. The third support level lies at $2.91 if the price breaches the second support level.
Achieve Life Sciences Inc (NASDAQ: ACHV) Key Stats
Market capitalization of the company is 106.26 million based on 34,390K outstanding shares. Right now, sales total 0 K and income totals -29,820 K. The company made 0 K in profit during its latest quarter, and -12,510 K in sales during its previous quarter.
